Bioidentical Hormones: Sound Science Or Bad Medicine : Hearing Before the Special Committee on Aging, United States Senate, One Hundred Tenth Congress, First Session, Washington, DC, April 19, 2007, Volume 4 |
Other editions - View all
Common terms and phrases
absolute excess risk American Medical Association analyses atherosclerosis baseline bioidentical hormones blood Boards of Pharmacy breast cancer cardiovascular disease Center cholesterol clinical trials colorectal cancer Committee on Aging compounded BHRT products compounded drugs compounded hormones compounded medications compounding pharmacies conjugated equine estrogen coronary heart disease death doctors dosage forms dose Downloaded from www.jama.com effects of hormone estradiol estrogen plus progestin follow-up global index hip fracture hormone replacement therapy hysterectomy increased risk Institute of Hlth JAMA levels Manson manufactured Medicine menopausal hormone therapy myocardial infarction National Institute observational studies outcomes patients person-years pharmaceutical pharmacists pharmacy compounding physicians placebo placebo group postmenopausal postmenopausal women prescribed prescription prevention prior progesterone randomized regulation Research risks and benefits Rossouw Senator SMITH standards testing total mortality treatment University Wiley Protocol women aged Women's Health Initiative www.jama.com at National